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GOYAL, R., ET AL.: Incidence of Lead System Malfunction Detected During Implantable Defibrillator
Generator Replacement. Implantable cardioverter-defibrillator (ICD) generator replacement due to a de-
pleted battery is a frequently performed procedure. Tbe frequency witb wbicb sensing and defibrillation
system failures are identified during device replacement procedures bas not been previously described.
Tberefore, tbe purpose of this study was to prospectively determine the frequency of lead system mal-
function detected at the time of device replacement in 55 consecutive patients undergoing ICD generator
replacement. The mean age of the patients was 63 ± 10 years and 40 of them were men. Forty-nine pa-
tients had an epicardial lead system, and six patients had a nonthoracotomy lead system. Four (7%) of
these 55 patients were noted to have previously undetected lead system failure, either sensing (n = 3) or
defibrillation (n = 1), necessitating system revision. The lead systems that failed were 40 ± 6 months old
(33-49 months). In summary, during ICD generator replacement, previously undetected problems with
sensing or defibrillation may be identified in approximately 10% of patients. Therefore, a comprehensive
evaluation of the sensing and the defibrillation functions sbould be an essential component of the ICD
generator replacement procedure. (PACE 1996; 19:1143-1146)
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Introduction
The utility of implantable cardioverter-defib-
rillators (ICDs) to protect against sudden cardiac
death has been well established.^"^ As the number
of patients with ICDs has increased, so has the
number of patients with devices that have devel-
oped battery depletion and require a generator re-
placement. The frequency with which defibrilla-
tion and sensing system failures are identified
during generator replacement procedures has not
previously been reported. Therefore, the purpose
of this study was to determine the value of com-
plete lead system assessment at the time of ICD re-
placement.
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The patient population consisted of 55 con-
secutive patients undergoing an ICD generator re-
placement between October 1993 and November
1994. One of the patients herein presented had el-
evated defibrillation energy requirements (DER)
and has been reported elsewhere.^ The mean age
of the patients was 63 ± 10 years, 40 males and 15
females. Forty-three patients had coronary artery
disease, 7 had idiopathic dilated cardiomyopathy,
3 had other forms of cardiomyopathy, and 2 had
structurally normal hearts. The mean left ventric-
ular ejection fraction was 0.29 ± 0.10. Thirty-five
of the 55 patients presented with a cardiac arrest,
16 presented with ventricular tachycardia, and 4
presented with syncope. Forty-nine patients had
an epicardial lead system, and 6 patients had a
nonthoracotomy lead system [CPI Endotak Sys-
tem, model 0064; tCardiac Pacemakers Inc., St.
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Paul, MN, USA] 2 patients also required a subcu-
taneous patch, model 0063). The epicardial defib-
rillation system v̂ âs composed of two epicardial
patches, and two screw-in sensing leads. The epi-
cardial patches were always manufactured by the
ICD manufacturer. The same was true of the sens-
ing leads, except that 23 patients with a CPI sys-
tem received Daig Corporation sensing leads
(model 501170, Minneapolis, MN, USA). The ini-
tial ICD was manufactured by Cardiac Pacemak-
ers, Inc. (CPI, St. Paul, MN, USA) in 49 patients, by
Intermedics, Inc. (Engleton, TX, USA) in 4 pa-
tients, and by Medtronic, Inc. (Minneapolis, MN,
USA) in 2 patients. The mean number of years
from ICD implant to ICD generator replacement
was 38 ± 7 months (28-48 months).
Routine ICD FoUovir-Up
All patients underwent routine outpatient
ICD evaluation of the sensing lead every 3 months
by one of the investigators. Sensing function was
assessed with a beep-o-gram for CPI devices, or
with real-time telemetry and R wave (mV) assess-
ment for Intermedics and Medtronic devices.
ICD Generator Replacement
ICD generator replacement was performed
when tbe battery status indicated, as recom-
mended by the manufacturer. At the time of ICD
generator replacement, the patients were brought
to tbe electropbysiology laboratory in a postab-
sorptive and unsedated state. Each patient signed
an informed consent prior to all procedures. The
site of tbe generator was inspected under fluo-
roscopy, to localize the header and its relative po-
sition to the lead(s). Sedation for the procedure
was achieved with a combination of intravenous
benzodiazepines and opiates. After infiltration
witb local anesthetic, an incision was made at tbe
site of the previous scar. Using blunt dissection,
the old generator was extracted and then discon-
nected from the leads. After demonstration of ad-
equate defibrillation and sensing function, a new
device was implanted, the pocket was irrigated
with a gentamicin solution, and the incision was
closed.
Replacement generators from CPI, Inter-
medics, Inc., Medtronic, Inc., and Ventritex (Sun-
nyville, CA, USA) were used. A CPI device (model
1555, 1600, 1625, 1700, 1705, or 1715) was im-
planted in 45 patients, an Intermedics RES-Q
(model 101-01) was implanted in 5 patients, a
Medtronic PCD (model 7217B) was implanted in 2
patients, and a Ventritex VllOC was implanted in
3 patients.
Assessment of Sensing Lead Function
After extraction of tbe ICD and disconnection
of the leads from tbe ICD, the sensing leads were
visually examined for a breach of insulator in-
tegrity. Tbe pacing threshold and lead impedance
were measured. If the insulation of the sensing
lead was observed to bave failed, or if tbe pacing
threshold was > 5 V, or the lead impedance was >




An adequate DER was defined as at least 10 J
less than the maximum output of the ICD. Ven-
tricular fibrillation was induced using alternating
current, and 10 seconds later a 20 J shock was de-
livered. If ventricular fibrillation was converted to
sinus rbytbm, an additional successful defibrilla-
tion at tbe same or less energy was required to
demonstrate an adequate DER. Defibrillation was
also tested with the device to ensure proper func-
tion. If tbe initial 20-J shock was unsuccessful,
then 25 J was used during tbe subsequent induc-
tion of ventricular fibrillation.
Statistical Analysis
Continuous variables are expressed as tbe
mean ± 1 SD.
Results
Major Findings
The ICD system was noted to be intact in 51 of
the 55 patients. The mean DER at tbe time of ICD
replacement was 16 ± 7 J (5-25 J). Lead system
failures were identified in 4 of the 55 patients, 40
± 6 months after lead system implantation (33—49
months). Sensing lead failure was identified in
three patients during tbe device replacement pro-
cedure, and failure to defibrillate was identified in
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one patient during assessment of the DER at the
time of ICD generator replacement, 40 ± 7 months
(33-49 months), and 41 months, respectively, af-
ter lead system implantation.
Sensing or Defibritlation System Faiture
In three patients with an epicardial lead sys-
tem, a sensing lead failure (model 501170, Daig
Corp., Minnetonka, MN, USA) was detected when
the defibrillator pocket was opened in the electro-
physiology laboratory and the sensing lead evalu-
ated. In addition to the identification of oversens-
ing in all of these patients, a high impedance (>
1000) was demonstrated in 2 patients, a pacing
threshold of > 5 V was observed in 3 patients, and
a visually apparent loss of insulator integrity was
noted in 1 patient. All three patients subsequently
underwent an uncomplicated sensing lead re-
placement with an endocardial lead via the sub-
clavian vein.
In one patient, an elevated DER was noted
during the replacement procedure with a
monophasic shock that was identical to the origi-
nal waveform. An adequate DER was achieved
when the original ICD was replaced without com-
plication using a biphasic device (CPI model
1625).
Discussion
This study demonstrates that approximately
10% of patients undergoing ICD generator re-
placement due to battery depletion may be found
to have a previously undetected sensing or defib-
rillation system failure. The usefulness of the
beep-o-gram to detect a sensing problem has been
previously reported.^'^ In this series, a clinically
undetected sensing lead abnormality was identi-
fied in three patients by direct evaluation of the
lead at the time of device replacement, despite
routine device surveillance.
Lead fractures of epicardial and nonthoraco-
tomy lead systems have been reported.^"^^ How-
ever, in these previous reports, the fractures were
usually discovered because of inappropriate
shocks or during the course of routine follow-
up.^~^'' The data from the present study are the
first data to suggest the importance of lead system
assessment during generator replacement.
In one patient in the present report, the DER
was noted to be unacceptably elevated 41 months
after implantation with an epicardial defibrillator
system. While energy requirements with an epi-
cardial lead system are not thought to change
chronically,^^ an elevation in the DER may occur
at least during the first 6 months after a nonthora-
cotomy lead system is implanted. ̂ ^ The results of
this study may not be generalizable to replace-
ment of ICDs in patients with nonthoracotomy
lead systems, although failure of nonthoracotomy
lead systems can also develop over time.̂ ^~^^ To-
gether, the results of prior and present studies sug-
gest that DER testing should be performed during
generator replacement.
Clinical Implications
Sensing lead function and defibrillation effi-
cacy should be carefully evaluated prior to and
during the replacement procedure. Evaluation of
lead system integrity may not be complete with a
noninvasive evaluation, and therefore, both defib-
rillation and sensing functions should be appro-
priately evaluated at the time of ICD generator re-
placement.
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